UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report: February 210, 2012

(Date of earliest event reported)

SCOLR Pharma, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-31982

91-1689591

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

19204 North Creek Parkway, Suite 100

Bothell, Washington 98011

(Address of principal executive offices and zip code)

(425) 368-1050

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

¨ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SCOLR PHARMA, INC.

FORM 8-K

Item 1.01 Entry into a Material Definitive Agreement.

On February 310, 2012, ~~SCOLR Pharma, Inc. (~~the “Company”) and ~~Emerson~~Brenner ~~Healthcare~~Construction ~~LLC~~Co. ~~(“Emerson”)~~d/b/a Brenner Properties entered into a ~~First Amendment (the “Amendment”) to Account Services~~lease ~~Agreement~~agreement, toeffective ~~amend~~as ~~certain provisions~~ of ~~the~~February ~~Account Services Agreement between the Company and Emerson~~7, ~~dated~~2012 ~~August 27, 2010~~ (the “~~Services Agreement~~Lease”)~~. Under the Services Agreement~~, ~~Emerson~~pursuant ~~provides certain account management, payment management and collections services~~ to which the Company inwill ~~support~~lease ofapproximately ~~the~~1,300 ~~Company’s~~square ~~nutritional~~feet ~~products~~of ~~business. The~~office ~~Amendment~~space ~~was~~at ~~entered~~13400 toNE ~~accommodate~~20th ~~the~~Street, ~~Company’s~~Bellevue, ~~cash flow needs~~Washington. The ~~Amendment~~term ~~provides that through December 31, 2012 Emerson will disburse to the Company 90%~~ of ~~each invoice issued by~~ the ~~Company~~lease tois ~~the~~13 ~~accounts~~months ofand ~~retail~~shall ~~customers~~commence ~~serviced~~on ~~by Emerson upon invoicing~~March 1, ~~up to an aggregate maximum $1~~2012.2 ~~million.~~ The Company ~~remaining~~intends ~~amount~~to ofrelocate ~~such invoices~~it ~~will~~headquarters befrom ~~remitted~~Bothell, byWashington, ~~Emerson~~ to the ~~Company~~new ~~upon~~space ~~collection,~~during ~~net of~~ the ~~fees,~~first ~~charges~~quarter ~~and~~of ~~withholdings previously contemplated by the Services Agreement~~2012. NoThe ~~additional~~monthly ~~fees~~base orrent ~~charges~~under ~~will be assessed to~~ the ~~Company~~lease asis a$1,793.00 ~~result~~per ~~of the Amendment~~month.

A copy of the ~~Amendment~~Lease is attached as Exhibit 10.1 to this current report and is incorporated herein. The foregoing description of the ~~Amendment~~ Lease does not purport to be complete and is qualified in its entirety by reference to such exhibit.

Item 52.0203. ~~Departure~~Creation of ~~Directors~~a orDirect Financial ~~Certain~~Obligation ~~Officers;~~or ~~Election~~an ofObligation ~~Directors;~~under ~~Appointment~~an ofOff-Balance ~~Certain~~Sheet ~~Officers;~~Arrangement ~~Compensatory Arrangements~~ of ~~Certain~~ ~~Officers~~a Registrant.

On February 2, 2012, the Company awarded to each of Stephen J. Turner, President and Chief Executive Officer, and Richard M. Levy, Executive Vice President and Chief Financial Officer, options to purchase 50,000 shares of common stock at an exercise price of $0.08 per share. The ~~options~~disclosure ~~were issued pursuant to the Company’s 2004~~contained ~~Equity~~under ~~Incentive Plan.~~Item ~~The~~1.01 ~~options~~above ~~will~~is ~~vest~~incorporated ininto ~~twelve~~this ~~equal~~item ~~monthly~~by ~~installments beginning on February 2, 2012~~reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		~~First Amendment to Account Services Agreement~~Lease, dated as of February 37, 2012, between SCOLR Pharma, Inc. and ~~Emerson~~Brenner ~~Healthcare~~Construction ~~LLC~~Co. d/b/a Brenner Properties.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SCOLR Pharma, Inc.

(Registrant)

February 8, 2012

/s/ RICHARD M. LEVY

February 14, 2012

/s/ RICHARD M. LEVY

Richard M. Levy

Executive Vice President & Chief Financial Officer

Filing Compare · SCOLR Pharma, Inc.